24 results
8-K
EX-99.1
TEVA
Teva- Pharmaceutical Industries Ltd.
8 May 24
Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook
7:01am
: the impact of global economic conditions and other macroeconomic developments and the governmental and societal responses thereto; the widespread
8-K
EX-99.1
TEVA
Teva- Pharmaceutical Industries Ltd.
31 Jan 24
Results of Operations and Financial Condition
7:00am
and the governmental and societal responses thereto; the widespread outbreak of an illness or any other communicable disease, or any other public
8-K
EX-99.1
jp9pan jephl7nx
8 Nov 23
2023 revenues outlook revised to $15.1 - $15.5 billion from $15.0 - $15.4 billion
7:01am
8-K
EX-99.1
kg2lruj1ego6ohkewul
4 Oct 23
Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatment
6:05am
8-K
b99i1 1bzbhv
4 Oct 23
Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatment
6:05am
8-K
EX-99.1
hauenq
24 Aug 23
Entry into a Material Definitive Agreement
7:30am
8-K
EX-99.1
eid7tysux
2 Aug 23
Results of Operations and Financial Condition
7:00am
8-K
EX-99.1
za1nohl
10 May 23
Results of Operations and Financial Condition
7:01am
8-K
EX-99.1
lvc4x7gzmh8h29isv
3 Nov 22
Key financial highlights and outlook
7:00am
8-K
EX-99.1
zuy8hz6atnatymn25
26 Jul 22
Key financial highlights and outlook
4:56pm
8-K
EX-99.1
x4jj2lat
3 May 22
Results of Operations and Financial Condition
7:01am